EP3436010
5-HT2A SEROTONIN RECEPTOR INVERSE AGONISTS OR ANTAGONISTS FOR USE IN REDUCING AMYLOID-BETA PEPTIDES AND ACCUMULATION OF AMYLOID PLAQUES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.3.2017EP published:
10.3.2021EP application number:
17719380.2
EPO information:
European Patent Register
Max expiry date:
27.3.2037
Title:
5-HT2A SEROTONIN RECEPTOR INVERSE AGONISTS OR ANTAGONISTS FOR USE IN REDUCING AMYLOID-BETA PEPTIDES AND ACCUMULATION OF AMYLOID PLAQUES
Timeline
Today
28.3.2017EP application
10.3.2021EP Publication
Owner
Name:
Acadia Pharmaceuticals Inc.Address:
12830 El Camino Real, Suite 400, San Diego, CA 92130, US
Inventor
Name:
BURSTEIN, EthanAddress:
San Diego, CA 92130, US
Priority
Number:
201662314857 PDate:
29.3.2016Country:
US
Number:
1630067Date:
4.4.2016Country:
SE
Classification
Categories:
A61K 31/445, A61K 31/4468, A61K 45/06, A61K 31/00, G01N 33/68, A61P 25/28